Angiodynamics to Release FY2026 Q1 Earnings on October 2, 2025, Pre-Market EST; Forecast Revenue USD 72.69M, EPS USD -0.2466
Brief Summary
AngioDynamics is expected to report Q1 2026 results with a projected revenue of $72.69 million and an EPS of -$0.2466.
Impact of The News
Performance Expectations: The anticipated revenue of $72.69 million and EPS of -$0.2466 for AngioDynamics’ Q1 2026 results suggest that the company may be underperforming compared to the benchmarks set by its peers in the medical technology sector. For example, companies like Micron Technology and Dell have shown substantial growth in revenue and profitability, as indicated by their recent financial results .
Market Position: Given the negative EPS, it appears AngioDynamics might be struggling in terms of profitability. This contrasts with the positive growth trends seen in the technology sector, where companies such as Micron have reported significant increases in revenue and profitability, with expectations to achieve even higher margins in upcoming quarters .
Business Outlook: The negative EPS might imply potential challenges in cost management or market competition for AngioDynamics. The company’s current financial position may require strategic adjustments, such as cost optimization or exploring new revenue streams, to improve future financial performance. Meanwhile, companies with strong revenue growth and positive profitability metrics are likely to continue attracting investor confidence and driving market share gains in their respective industries .
